The store will not work correctly when cookies are disabled.
N-(4-(((5-Bromothiophen-2-yl)methyl)amino)-2-chlorophenyl)-5-chloro-2-hydroxybenzamide
ID: ALA4757217
PubChem CID: 162657056
Max Phase: Preclinical
Molecular Formula: C18H13BrCl2N2O2S
Molecular Weight: 472.19
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(NCc2ccc(Br)s2)cc1Cl)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C18H13BrCl2N2O2S/c19-17-6-3-12(26-17)9-22-11-2-4-15(14(21)8-11)23-18(25)13-7-10(20)1-5-16(13)24/h1-8,22,24H,9H2,(H,23,25)
Standard InChI Key: FRNFXFUGYIUNDA-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
9.8610 -8.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1556 -8.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4470 -8.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7416 -8.6858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7449 -9.5030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4535 -9.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1589 -9.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8578 -7.4451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5738 -8.6686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4438 -7.4537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4608 -10.7224 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.2792 -8.2536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9878 -8.6600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6932 -8.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6858 -7.4279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9772 -7.0256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2718 -7.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9910 -9.4771 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.3912 -7.0170 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1040 -7.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8094 -7.0084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5555 -7.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0979 -6.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6870 -6.0193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8902 -6.1931 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.0147 -5.2732 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
3 10 1 0
6 11 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
13 18 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
21 25 1 0
24 26 1 0
20 21 1 0
19 20 1 0
15 19 1 0
9 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 472.19 | Molecular Weight (Monoisotopic): 469.9258 | AlogP: 6.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 61.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.39 | CX Basic pKa: 3.12 | CX LogP: 6.01 | CX LogD: 5.71 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.40 | Np Likeness Score: -2.10 |
References
1. Xu J,Berastegui-Cabrera J,Ye N,Carretero-Ledesma M,Pachón-Díaz J,Chen H,Pachón-Ibáñez ME,Sánchez-Céspedes J,Zhou J. (2020) Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors., 63 (21): [PMID:33112138] [10.1021/acs.jmedchem.0c01226] |